We are live on ! Find out more

60 hedge funds and large institutions have $12.6M invested in PAVmed in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

15% more funds holding

Funds holding: 5260 (+8)

0% less ownership

Funds ownership: 0.03%0.03% (-0%)

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

11% less capital invested

Capital invested by funds: $14.2M → $12.6M (-$1.58M)

Holders
60
Holders Change
+8
Holders Change %
+15.38%
% of All Funds
1.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
13
Reduced
14
Closed
4
Calls
Puts
Net Calls
Net Calls Change

PAVM Hedge Fund Activity: Q3 2020 in Review

60 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q3 2020, worth a combined $12.6M — down 11% from $14.2M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new PAVM positions and 4 closed out — a net gain of 8 holders — while 13 added to existing stakes and 14 trimmed.

The largest buyer was Northern Trust, adding an estimated $571K. The largest seller was EAM Investors, exiting entirely with an estimated $706K sold.

  • 60 institutional investors held PAVmed (PAVM) as of Q3 2020, up from 52 in Q2 2020.
  • Funds reported $12.6M of PAVmed stock for Q3 2020, down 11% quarter-over-quarter.
  • 12 funds opened new PAVmed positions in Q3 2020 and 4 closed out, a net change of +8 holders.
  • The largest PAVmed buyer in Q3 2020 was Northern Trust, an estimated $571K added.
  • The largest PAVmed seller in Q3 2020 was EAM Investors, an estimated $706K sold.

Based on aggregated 13F filings for Q3 2020.